- Advertise
- Contact Us
- Contribute
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
- About Us
© 2022 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
All News
Study Finds Flash Glucose Monitoring Could Prompt Lifestyle Changes in Prediabetes
November 21, 2022
A single-arm study provides insight into the feasibility and acceptability of flash glucose monitoring use for promoting positive lifestyle changes among people with prediabetes.
People with Type 2 Diabetes at Greater Risk of Having Advanced Stage Cancer at Time of Diagnosis
November 19, 2022
An analysis of data from the EPIC study provides insight into an apparent increase in risk of having an advanced stage cancer at time of diagnosis for patients with cardiometabolic diseases compared to their counterparts without cardiometabolic diseases.
Diabetes Dialogue: What Teplizumab Means for Type 1 Diabetes
November 17, 2022
In this special edition episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, break down what the approval of teplizumab means for type 1 diabetes. During the episode, hosts take a deep dive into type 1 diabetes staging and hypothesize around the role of CDCES in educating primary care and other specialties to optimize the potential of teplizumab.
FDA Issues Recall for Insulet Devices for Battery, Overheating Issues that Could Cause Fire
November 17, 2022
Announced on November 17, the US FDA Class I recall for the Insulet Omnipod DASH Insulin Management System Personal Diabetes Manager comes after the company had received more than 450 complaints related to battery swelling, fluid leakage from battery, and extreme overheating, including 3 instances that included fires.
Key Takeaways from the ADA-KDIGO Consensus Statement on CKD, with Kim Zuber, MS, PA-C, and Jane Davis, DNP
November 17, 2022
Kim Zuber, MS, PA-C, and Jane Davis, DNP, provide perspective on the recent consensus statement on management of chronic kidney disease from the American Diabetes Association and the Kidney Disease Improving Global Outcomes group.
Study Details Predictors of Diabetes in People with Chronic Pancreatitis
November 16, 2022
A Cedars-Sinai-led analysis of data from the PROCEED study provides insight into risk factors and clinical predictors of diabetes among a cohort of adult patients with chronic pancreatitis.
Flash Monitoring Could Prove Useful for Glucose Monitoring in Hemodialysis, Regardless of Diabetes Status
November 15, 2022
A 15-person study comparing flash monitoring to standard self-monitoring in people on hemodialysis with or without diabetes provides clinicians and researchers with insight into the potential clinical applicability of these devices in similar patient populations.
Diabetes Dialogue: Obesity Updates, with Lydia Alexander, MD
November 14, 2022
In this episode, our hosts are joined by Lydia Alexander, MD, president-elect of the Obesity Medicine Association, to discuss the updates in the landscape of obesity management as well as a deep dive into the recent American Gastroenterological Association guidelines for pharmacological management and the OMA's annual meeting.
Endocrine Case Report: Thigh Pain
November 11, 2022
Our latest endocrine case report from Brady Pregerson, MD, features a female in her 60s with a history of diabetes mellitus who presents to the ED for 3 days of inner right thigh pain. Can you determine the correct diagnosis?
Study Finds Dexcom G7 Setup is Easier, Requires Fewer Tasks for Older Adults than Previous Generations
November 10, 2022
A formal task analysis conducted in older adults with type 2 diabetes provides insight into the ease of use and task burden associated with uptake of the Dexcom G7 CGM system, with results indicating use of the system required fewer than half as many steps to initiate as previous generations of the CGM system.